Impact of sotagliflozin on glomerular hyperfiltration in people with type 1 diabetes: A post hoc analysis of the inTandem3 trial

Documenti analoghi

• Effects of sotagliflozin on markers of volume status and sodium handling in patients with type 1 diabetes: A biomarker analysis of the inTandem3 clinical trial
  di: Massimo Nardone, et al.
  Pubblicazione: (2026)
• Effects of sotagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease stages 3 and 4
  di: Vikas S. Sridhar, et al.
  Pubblicazione: (2024)
• Age‐ and gender‐adjusted estimated glomerular filtration rate definition reveals hyperfiltration as a risk factor for renal function deterioration in type 2 diabetes
  di: Wei‐Lun Wen, et al.
  Pubblicazione: (2024)
• Effect of semaglutide on primary prevention of diabetic kidney disease in people with type 2 diabetes: A post hoc analysis of the SUSTAIN 6 randomized controlled trial
  di: Jingyu Wang, et al.
  Pubblicazione: (2024)
• Health‐related quality of life of people with type 1 diabetes: An IMI2 SOPHIA post hoc analysis of FUTURE and ADJUNCT ‐ ONE
  di: Nele Steenackers, et al.
  Pubblicazione: (2024)